1. W. J. Bateman, R. Fiera, N. Matthews, A. G. Morris, Inducibility of class II major histocompatibility complex antigens by interferon-γ is associated with reduced tumorigenicity in C3H mouse fibroblasts transformed by v-Ki-ras, J. Exp. Med., 173: 193–196 (1991)
2. R. F. L. James, S. Edwards, K. M. Hui, P.D. Bassett, F. Grosveld, The effect of class II gene transfection on the tumorigenicity of the H-2K-negative mouse leukaemia cell line K36.16, Immunology, 72: 213–218 (1991)
3. S. O-Rosenberg, A. Thakur, V. Clements, Rejection of mouse sarcoma cells after transfection of MHC class II genes, J. Immunol., 144: 4068–4071 (1990)
4. G. J. Hammerling, D. Klar, W. Pulm, F. Momburg, G. Moldenhauer, The influence of major histocompatibility complex class I antigens on tumour growth and metastasis, Biochim. Biophys. Acta, 907:245–259 (1987)
5. T. P. Miller, S. M. Lippman, C. M. Spier, D. J. Slymen, T. M. Grogan, HLA-DR (Ia) antigen immune phenotype predicts outcome for patients with diffuse large cell lymphoma, J. Clin. Invest., 82: 370–372 (1988)